Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Armata Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ARMP
NYSE American
2836
www.armatapharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Armata Pharmaceuticals, Inc.
/C O R R E C T I O N -- Armata Pharmaceuticals, Inc./
- Jan 13th, 2026 5:42 am
Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST
- Nov 18th, 2025 5:00 am
Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates
- Nov 12th, 2025 3:25 pm
Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update
- Nov 12th, 2025 2:05 pm
Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates
- Nov 10th, 2025 6:40 am
Armata Pharmaceuticals Announces Formal Commissioning of State-of-the-Art cGMP Phage Manufacturing Facility in Los Angeles, California
- Nov 10th, 2025 5:00 am
Coherus Oncology (CHRS) Reports Q3 Loss, Lags Revenue Estimates
- Nov 6th, 2025 6:15 pm
Exact Sciences (EXAS) Q3 Earnings and Revenues Beat Estimates
- Nov 3rd, 2025 4:05 pm
Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains?
- Oct 23rd, 2025 5:10 am
Armata Pharmaceuticals Highlights Positive Results from Phase 2a diSArm Study of its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, in Late-Breaking Oral Presentation at IDWeek 2025™
- Oct 22nd, 2025 9:10 am
Armata Pharmaceuticals to Present Late-Breaking Clinical Data highlighting its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, at IDWeek 2025™
- Oct 14th, 2025 5:00 am
Are Medical Stocks Lagging Armata Pharmaceuticals (ARMP) This Year?
- Oct 6th, 2025 7:40 am
Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year?
- Sep 18th, 2025 7:40 am
Armata Pharmaceuticals Announces Structural Biology Publication in the Journal of Molecular Biology
- Sep 8th, 2025 5:00 am
Armata Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
- Sep 4th, 2025 5:00 am
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?
- Sep 1st, 2025 7:40 am
All You Need to Know About Armata Pharmaceuticals (ARMP) Rating Upgrade to Buy
- Aug 15th, 2025 10:00 am
Is Armata Pharmaceuticals (ARMP) Outperforming Other Medical Stocks This Year?
- Aug 15th, 2025 7:40 am
Armata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Beats Revenue Estimates
- Aug 12th, 2025 3:40 pm
Armata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update
- Aug 12th, 2025 2:05 pm
Scroll